Brazil vs Bulgaria: The number of people with susceptibility test result for rifampicin
Brazil
50.47
in 2021
Bulgaria
47.71
in 2021
Brazil rank
114th
Bulgaria rank
115th
The number of people with susceptibility test result for rifampicin over time
- Brazil
- Bulgaria
How they compare
Brazil currently reports 50.47 against 47.71 in Bulgaria, a difference of 2.76.
That makes Brazil's figure about 1.1 times Bulgaria's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Bulgaria ahead.
Brazil ranks 114th and Bulgaria ranks 115th of 146 countries.
Across the 2 decades both report, Brazil averaged higher in 1 and Bulgaria in 1.
Head to head by decade
| Decade | Brazil | Bulgaria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 41.74 | 80.4 | 38.66 | Bulgaria |
| 2020s | 51.96 | 49.92 | 2.03 | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Brazil or Bulgaria?
- Brazil, at 50.47 against 47.71 in Bulgaria as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Brazil and Bulgaria?
- 2.76, with Brazil ahead.
- How many years of comparable data are there for Brazil and Bulgaria?
- 5 years are reported by both, from 2017 to 2021.
- How do Brazil and Bulgaria rank globally for the number of people with susceptibility test result for rifampicin?
- Brazil ranks 114th and Bulgaria ranks 115th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.